Orfonyx Bio
PrivateLast Round
Seed
Apr 9, 2025
Company Overview
Orfonyx Bio is a biotechnology company developing a new class of genetic medicines that enhance gene expression by targeting regulatory elements in untranslated regions of genes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Orfonyx Bio Comparables
Compare Orfonyx Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ribometrix | 86% | |
| Rgenta Therapeutics | 79% | |
| Ochre Bio | 78% |
Orfonyx Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 9, 2025 |
Key People
Founding team and executive leadership
Orfonyx Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Oxford Science Enterprises | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 12, 2025
Grew 43% QoQ from 7 to 10 employees.
- Oct 24, 2024
Grew 75% QoQ from 4 to 7 employees.
Orfonyx Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Orfonyx Bio's valuation, stock price, and market status.
Is Orfonyx Bio a public or private company?
Orfonyx Bio is a private company.
What is the current stock price of Orfonyx Bio?
Orfonyx Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Orfonyx Bio worth (valuation)?
Valuation information for Orfonyx Bio is not publicly available.
Can I buy Orfonyx Bio stock?
Orfonyx Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Orfonyx Bio's last funding round?
Orfonyx Bio's most recent funding round was Seed on April 9, 2025.
Who are the main investors in Orfonyx Bio?
Key investors in Orfonyx Bio include Oxford Science Enterprises.
Will Orfonyx Bio IPO soon?
No public IPO plans have been announced for Orfonyx Bio.
How can I track Orfonyx Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Orfonyx Bio's secondary market activity and sign up for updates.